SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chien-Hung Chen, Sheng-Nan Lu, Chuan-Mo Lee, Chao-Hung Hung, Jing-Houng Wang, Tsung-Hui Hu, Patients with interferon-induced HBeAg seroconversion have a higher risk of HBV reactivation and HBeAg seroreversion, Hepatology International, 2014, 8, 3, 365

    CrossRef

  2. 2
    Ling-Na Kong, Bo Qin, Qian Ma, Lin Li, Yu Yao, Relationship between hepatitis B virus genotype B and C and response to interferon therapy in HBeAg positive chronic hepatitis B patients: A meta-analysis, Journal of Gastroenterology and Hepatology, 2014, 29, 7
  3. 3
    Phunchai Charatcharoenwitthaya, Teerha Piratvisuth, Baseline and On-treatment Predictors of Chronic Hepatitis B Patients Receiving Pegylated Interferon Therapy in Asia, Current Hepatitis Reports, 2013, 12, 3, 165

    CrossRef

  4. 4
    Eleftherios Michailidis, Karen A. Kirby, Atsuko Hachiya, Wangdon Yoo, Sun Pyo Hong, Soo-Ok Kim, William R. Folk, Stefan G. Sarafianos, Antiviral therapies: Focus on hepatitis B reverse transcriptase, The International Journal of Biochemistry & Cell Biology, 2012, 44, 7, 1060

    CrossRef

  5. 5
    Sudeep Tanwar, Geoffrey Dusheiko, Is There Any Value to Hepatitis B Virus Genotype Analysis?, Current Gastroenterology Reports, 2012, 14, 1, 37

    CrossRef

  6. 6
    Chao-Hung Hung, Chien-Hung Chen, Sheng-Nan Lu, Jing-Houng Wang, Tsung-Hui Hu, Chao-Min Huang, Ming-Chao Tsai, Chuan-Mo Lee, Precore/core promoter mutations and hepatitis B virus genotype in hepatitis B and C dually infected patients treated with interferon-based therapy, Antiviral Research, 2012, 93, 1, 55

    CrossRef